S-16924 [(R)-2-{1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)ethyl]- pyrrolidin-3yl}-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin(1A) agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1002-1014

  Millan, Mark J ^a   Brocco, Mauricette ^a   Gobert, Alain ^a   Schreiber, Rudy ^a   Dekeyne, Anne ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA [1 [2 (1,4 BENZODIOXAN 5 YLOXY)ETHYL] 3 PYRROLIDINYL] 4 FLUOROACETOPHENONE; ANXIOLYTIC AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; SEROTONIN 1A AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; LOCOMOTION; MALE; NONHUMAN; PIGEON; PRIORITY JOURNAL; PSYCHOSIS; RAT;

AGGRESSION; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORECEPTORS; CLORAZEPATE DIPOTASSIUM; CLOZAPINE; COLUMBIDAE; CONFLICT (PSYCHOLOGY); HALOPERIDOL; MALE; MAZE LEARNING; MICE; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TIME FACTORS; VOCALIZATION, ANIMAL;

EID: 0033015420     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Arzin N (1959) Technique for delivering shock to pigeons. J Exp Anal Behav 2:161-163.
2. Barnes NM, Costall AM, Domeney PA, Gerrard PA, Kelly ME, Krähling H, Naylor RJ, Tomkins DM and Williams TJ (1991) The effects of umespirone as a potential anxiolytic and antipsychotic agent. Pharmacol Biochem Behav 40:89-96.
3. Borowski TB and Kokkinidis L (1996) Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: Effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion on potentiated startle in rats. Behav Neurosci 110:1349-1364.
4. Brunello N, Masotto C, Steardo L, Markstein R and Racagni G (1995) New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13:177-213.
5. 4 receptor and anxiety: Behavioural profiles of clozapine, L-745,870 and L 741,742 in the mouse plus-maze. Eur J Pharmacol 335:117-125.
6. 3) receptor antagonists increase rates of punished responding in rats. Pharmacol Biochem Behav 4:671-676.
7. 1A receptors mediate the effect of ipsapirone on punished responding in rats. Eur J Pharmacol 284:249-255.
8. 1A antagonist, WAY100635. Psychopharmacology 132:35-43.
9. 1A receptor, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 1301-1310, Raven Press, New York.
10. Corbett R, Hartman H, Kerman LL, Woods AT, Strupczewski JT, Helsley GC, Conway PC and Dunn RW (1993) Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol Biochem Behav 45:9-17.
11. 3 receptor agonists and antagonists for alteration of aversive behaviour in the mouse. Br J Pharmacol 96:325-332.
12. Eison AS and Eison MS (1994) Serotonergic mechanisms in anxiety. Prog NeuroPsychopharmacol Biol Psychiatr 18:47-62.
13. Ellenbroek BA, Lubbers LJ and Cools AR (1996) Activity of "seroquel" (ICI204,636) in animal models for atypical properties of antipsychotics: A comparison with clozapine. Neuropsychopharmacol 15:406-416.
14. Espejo EF (1997) Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res 762:281-284.
15. 1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16:4810-4815.
16. Gammans RE, Stringfellow JC, Hvizdos AJ, Seidehamel RJ, Cohn JB, Wilcox CS, Fabre LF, Pecknold JC, Smith WT and Rickels K (1992) Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. Neuropsychobiology 25:193-201.
17. 2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology 36:793-802.
18. 2C receptors. Neuropharmacology 35:1355-1363.
19. Kahn RS and Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139-1166.
20. 2B receptor agonist, BW 723C86, on three rat models of anxiety. Br J Pharmacol 117:1443-1448.
21. 2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117:427-434.
22. 1A receptor ligands in a modified Geller-Seifter conflict model in the rat. Eur J Pharmacol 325:121-128.
23. 1A receptors. Eur J Pharmacol 260:79-83.
24. Mansbach RS, Harrod C, Hoffmann SM, Nader MA, Lei Z, Witkin JM and Barrett JE (1988) Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther 246:114-120.
25. A and 5-HT anxiolytics. Psychopharmacology 121: 38-56.
26. 1C/2 antagonists as therapeutic agents. Drug News Perspect 5:397-406.
27. 1A agonist properties. I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol. J Pharmacol Exp Ther. 286:1341-1355.
28. 1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. J Pharmacol Exp Ther 282:148-161.
29. 1A agonist properties. II: Functional profile in comparison to clozapine and haloperidol J Pharmacol Exp Ther 286:1356-1373.
30. Moore NA, Rees G, Sanger G and Tye NC (1994) Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5:196-202.
31. 1A receptors. Neuropharmacology 35:119-121.
32. Pan ZZ and Williams JT (1989) GABA- and glutamate-mediated synaptic potentials in rat dorsal raphe neurons in vitro. J Neurophysiol 61:719-726.
33. Rigdon GC, Norman MH, Cooper BR, Howard JL, Boncek VM, Faison WL, Nanry KP and Pollard GT (1996) 1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects. Neuropsychopharmacology 15:231-242.
34. Roth BL and Meltzer HY (1995) The role of serotonin in schizophrenia, in Psychopharmacology: The Fourth Generation, of Progress (Bloom FE and Kupfer DJ eds) pp 1215-1228, Raven Press, New York.
35. Sanchez C and Arnt J (1995) Different anxiolytic-like profiles of novel antipsychotics in rodents. Am Soc Neurosci Abstr 21:2107.
36. Sanchez C, Arnt J, Dragsted N, Hyttel J, Lembøl HL, Meier E, Perregaard J and Skarsfeldt T (1991) Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Dev Res 22:239-250.
37. 1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms of actions? Prog NeuroPsychopharmacol Biol Psychiatr 17:87-104.
38. Söderpalm B and Engel JA (1988) Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors. Pharmacol Biochem Behav 30:471-477.
39. Spealman RD and Katz JL (1980) Some effects of clozapine on punished responding by mice and squirrel monkeys. J Pharmacol Exp Ther 212:435-440.
40. Spealman RD, Kelleher RT, Goldberg SR, DeWeese J and Goldberg (1983) Behavioral effects of clozapine: Comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys. J Pharmacol Exp Ther 224:127-134.
41. Wiley JL, Compton AD and Porter JH (1993) Effects of four antipsychotics on punished responding in rats. Pharmacol Biochem Behav 46:263-267.
42. Wirsching WC, Marder SR, Van Putten T and Ames D (1995) Acute treatment of schizophrenia, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 1259-1266, Raven Press, New York.